uric acid and thalidomide

uric acid has been researched along with thalidomide in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Fricker, J1
Afridi, F; Kar, P; King-Morris, K; Komarla, A; Perrone, D1
Boggio, E; Bruna, R; Crisà, E; De Paoli, L; Dianzani, U; Gaidano, G; Gigliotti, L; Margiotta Casaluci, G; Moia, R; Patriarca, A; Rolla, R1
Ali, M; Ali, Z; Ismail, M; Khan, MTM; Rani, GF; Rehman, IU1

Trials

1 trial(s) available for uric acid and thalidomide

ArticleYear
Long-term clinical efficacy and safety of thalidomide in patients with transfusion-dependent β-thalassemia: results from Thal-Thalido study.
    Scientific reports, 2023, 08-21, Volume: 13, Issue:1

    Topics: beta-Thalassemia; Ferritins; Humans; Hydroxyurea; Thalidomide; Treatment Outcome; Uric Acid

2023

Other Studies

3 other study(ies) available for uric acid and thalidomide

ArticleYear
50th ASH Annual Meeting.
    The Lancet. Oncology, 2009, Volume: 10, Issue:1

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Humans; Lenalidomide; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Nadroparin; Rituximab; Thalidomide; Thromboembolism; Uric Acid

2009
Proximal Renal Tubular Acidosis (Fanconi Syndrome) Induced by Apremilast: A Case Report.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2017, Volume: 70, Issue:5

    Topics: Acidosis; Acidosis, Renal Tubular; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Psoriatic; Fanconi Syndrome; Humans; Hypokalemia; Male; Proteinuria; Thalidomide; Uric Acid

2017
Anti-rasburicase antibodies induce clinical refractoriness by inhibiting the enzyme catalytic activity.
    Hematological oncology, 2020, Volume: 38, Issue:2

    Topics: Acute Kidney Injury; Aged; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Bortezomib; Dexamethasone; Female; Humans; Multiple Myeloma; Prognosis; Thalidomide; Urate Oxidase; Uric Acid

2020